相似文献
1
Clinical and genetic evaluation after sudden cardiac arrest.
J Cardiovasc Electrophysiol. 2020 Feb;31(2):570-578. doi: 10.1111/jce.14333. Epub 2020 Jan 15.
2
Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.
Cardiovasc Res. 2020 Jul 15;116(9):1600-1619. doi: 10.1093/cvr/cvaa116.
3
Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.
Rev Esp Cardiol (Engl Ed). 2017 Oct;70(10):808-816. doi: 10.1016/j.rec.2017.04.024. Epub 2017 May 26.
4
Role of risk stratification and genetics in sudden cardiac death.
Can J Physiol Pharmacol. 2017 Mar;95(3):225-238. doi: 10.1139/cjpp-2016-0457. Epub 2016 Oct 16.
5
Sudden cardiac arrest in infants and children: proposal for a diagnostic workup to identify the etiology. An 18-year multicenter evaluation in the Netherlands.
Eur J Pediatr. 2024 Jan;183(1):335-344. doi: 10.1007/s00431-023-05301-9. Epub 2023 Oct 27.
6
A comparison of genetic findings in sudden cardiac death victims and cardiac patients: the importance of phenotypic classification.
Europace. 2015 Mar;17(3):350-7. doi: 10.1093/europace/euu210. Epub 2014 Oct 26.
7
Family-based cardiac screening in relatives of victims of sudden arrhythmic death syndrome.
Europace. 2013 Jul;15(7):1050-8. doi: 10.1093/europace/eus408. Epub 2013 Feb 3.
8
Genetics of sudden cardiac arrest.
Prog Cardiovasc Dis. 2008 May-Jun;50(6):390-403. doi: 10.1016/j.pcad.2007.10.006.
9
Sudden arrhythmia death syndrome in young victims: a five-year retrospective review and two-year prospective molecular autopsy study by next-generation sequencing and clinical evaluation of their first-degree relatives.
Hong Kong Med J. 2019 Feb;25(1):21-9. doi: 10.12809/hkmj187256. Epub 2019 Jan 23.
10
Molecular autopsy of sudden unexplained deaths reveals genetic predispositions for cardiac diseases among young forensic cases.
Europace. 2017 Nov 1;19(11):1881-1890. doi: 10.1093/europace/euw247.
引用本文的文献
1
"Re-evaluation of variants of uncertain significance in patients with hereditary arrhythmogenic disorders".
BMC Cardiovasc Disord. 2024 Jul 27;24(1):390. doi: 10.1186/s12872-024-04065-w.
2
Molecular autopsy for sudden death in Japan.
J Toxicol Pathol. 2024 Jan;37(1):1-10. doi: 10.1293/tox.2023-0080. Epub 2023 Aug 30.
3
Sudden Cardiac Arrest in the Paediatric Population.
CJC Pediatr Congenit Heart Dis. 2022 Feb 10;1(2):45-59. doi: 10.1016/j.cjcpc.2022.02.001. eCollection 2022 Apr.
4
Post-mortem genetic testing in sudden cardiac death and genetic screening of relatives at risk: lessons learned from a Czech pilot multidisciplinary study.
Int J Legal Med. 2023 Nov;137(6):1787-1801. doi: 10.1007/s00414-023-03007-z. Epub 2023 May 13.
5
Sudden Cardiac Death in Young Individuals: A Current Review of Evaluation, Screening and Prevention.
J Clin Med Res. 2023 Jan;15(1):1-9. doi: 10.14740/jocmr4823. Epub 2023 Jan 24.
6
Type 2 Diabetes and Causes of Sudden Cardiac Death: A Systematic Review.
Cureus. 2021 Sep 20;13(9):e18145. doi: 10.7759/cureus.18145. eCollection 2021 Sep.
7
Hypoplastic Coronary Artery Disease Presenting with Ventricular Fibrillation Cardiac Arrest.
Eur J Case Rep Intern Med. 2021 Aug 2;8(8):002736. doi: 10.12890/2021_002736. eCollection 2021.
8
Sudden cardiac death-update.
Int J Legal Med. 2021 Mar;135(2):483-495. doi: 10.1007/s00414-020-02481-z. Epub 2020 Dec 21.
本文引用的文献
1
The yield of postmortem genetic testing in sudden death cases with structural findings at autopsy.
Eur J Hum Genet. 2020 Jan;28(1):17-22. doi: 10.1038/s41431-019-0500-8. Epub 2019 Sep 18.
2
The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication.
Mol Genet Genomic Med. 2019 Nov;7(11):e940. doi: 10.1002/mgg3.940. Epub 2019 Sep 3.
3
Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.
Circ Genom Precis Med. 2019 Jun;12(6):e000054. doi: 10.1161/HCG.0000000000000054. Epub 2019 May 23.
4
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.
Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.
5
Usefulness of Genetic Testing in Sudden Cardiac Arrest Survivors With or Without Previous Clinical Evidence of Heart Disease.
Am J Cardiol. 2019 Jun 15;123(12):2031-2038. doi: 10.1016/j.amjcard.2019.02.061. Epub 2019 Mar 18.
6
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Circ Genom Precis Med. 2019 Feb;12(2):e002460. doi: 10.1161/CIRCGEN.119.002460.
7
Psychological adaptation to molecular autopsy findings following sudden cardiac death in the young.
Genet Med. 2019 Jun;21(6):1452-1456. doi: 10.1038/s41436-018-0338-4. Epub 2018 Oct 16.
8
Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.
J Am Coll Cardiol. 2018 Jul 24;72(4):419-429. doi: 10.1016/j.jacc.2018.04.078.
9
Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy.
Genet Med. 2019 Mar;21(3):650-662. doi: 10.1038/s41436-018-0084-7. Epub 2018 Jul 2.
10
Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome.
Circulation. 2018 Sep 18;138(12):1195-1205. doi: 10.1161/CIRCULATIONAHA.118.035070.
Zotero 插件